Relevance of compartmentalization of T-cell subsets for clinical improvement in psoriasis: effect of immune-targeted antipsoriatic therapies

Autor: P.C.M. van de Kerkhof, Annechien M. G. Langewouters, J.E.M. Körver, E.M.G.J. de Jong, D.W.A. Van Rens, Jan B.M. Boezeman, Marieke M B Seyger, R.G. van Lingen, M.A.M. Berends

Publikováno v: British Journal of Dermatology, 159, 91-6
British Journal of Dermatology, 159, 1, pp. 91-6

Contains fulltext : 71209.pdf (Publisher’s version ) (Closed access) BACKGROUND: Therapies targeting the T cell-mediated pathology of psoriasis have been found to achieve remarkable clinical improvement and have confirmed the crucial role of the im

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::607aaab25b3378bc9f480e0ea0443230
https://hdl.handle.net/2066/71209

Therapeutic effects of a 12-week course of alefacept on nail psoriasis

Autor: J.E.M. Körver, P.C.M. van de Kerkhof, Annechien M. G. Langewouters, Marcel C. Pasch

Publikováno v: JEADV : Journal of the European Academy of Dermatology and Venereology, 20, 10, pp. 1252-5
JEADV : Journal of the European Academy of Dermatology and Venereology, 20, 1252-5

Contains fulltext : 50206.pdf (Publisher’s version ) (Closed access) BACKGROUND AND OBJECTIVES: Nail psoriasis is a common finding in psoriatic patients and it affects the quality of life in a great proportion of patients. Topical or systemic treat

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::8e7840a4818caa5d7d8d90e9e9b10df5
https://doi.org/10.1111/j.1468-3083.2006.01783.x

Severe pyoderma gangrenosum unresponsive to etanercept and adalimumab

Autor: M.M. Kleinpenning, Annechien M. G. Langewouters, Rens J Greebe, P.C.M. Kerkhof

Publikováno v: Journal of Dermatological Treatment, 22, 5, pp. 261-5
Journal of Dermatological Treatment, 22, 261-5

Item does not contain fulltext BACKGROUND: A 74-year-old female with severe and therapy-resistant pyoderma gangrenosum (PG) was treated for more than 40 years with topical antibacterial ointments, topical and systemic corticosteroids, dapsone and aza

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::7ee44e70de1f59eabfec886f216604d0
https://doi.org/10.3109/09546631003797106

The added therapeutic efficacy and safety of alefacept in combination with other (systemic) anti-psoriatics in refractory psoriasis

Autor: Piet E.J. van Erp, Elke M G J de Jong, Annechien M. G. Langewouters, Peter C.M. van de Kerkhof

Publikováno v: The Journal of dermatological treatment. 17(6)

Alefacept is a biologic treatment for psoriasis, with a selective effect on memory effector T cells. Few data are available on the combination of alefacept with either topical or systemic anti-psoriatics. We studied the effect of alefacept combinatio

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::83d91a5a5eda2d86227baf043a038cf6
https://pubmed.ncbi.nlm.nih.gov/17853311

Etanercept and efalizumab treatment for high-need psoriasis. Effects and side effects in a prospective cohort study in outpatient clinical practice

Autor: M.A.M. Berends, Jan B.M. Boezeman, Elke M G J de Jong, Peter C.M. van de Kerkhof, R.J.B. Driessen, Annechien M. G. Langewouters

Publikováno v: Journal of Dermatological Treatment, 18, 76-83
Journal of Dermatological Treatment, 18, 2, pp. 76-83

Contains fulltext : 52028.pdf (Publisher’s version ) (Closed access) BACKGROUND: Since the beginning of 2005, etanercept and efalizumab are officially registered and reimbursed for the treatment of recalcitrant psoriasis in The Netherlands. OBJECTI

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::960a6af05f09fed571d210e30e5f5f4b
https://doi.org/10.1080/09546630601121086